These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15147317)

  • 1. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo.
    Klyubin I; Walsh DM; Cullen WK; Fadeeva JV; Anwyl R; Selkoe DJ; Rowan MJ
    Eur J Neurosci; 2004 May; 19(10):2839-46. PubMed ID: 15147317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo.
    Zhang JM; Wu MN; Qi JS; Qiao JT
    Synapse; 2006 Sep; 60(4):307-13. PubMed ID: 16786537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.
    Zhang JF; Qi JS; Qiao JT
    Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil.
    Freir DB; Costello DA; Herron CE
    J Neurophysiol; 2003 Jun; 89(6):3061-9. PubMed ID: 12611943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulus pattern dependence of the Alzheimer's disease amyloid-beta 42 peptide's inhibition of long term potentiation in mouse hippocampal slices.
    Smith JP; Lal V; Bowser D; Cappai R; Masters CL; Ciccotosto GD
    Brain Res; 2009 May; 1269():176-84. PubMed ID: 19302985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
    Bisel BE; Henkins KM; Parfitt KD
    Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices.
    Zhang W; Miao J; Hao J; Li Z; Xu J; Liu R; Cao F; Wang R; Chen J; Li Z
    Peptides; 2009 Jun; 30(6):1197-202. PubMed ID: 19463756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W; Guo F; Cheng L; Zhang JF; Qi JS
    Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid.
    Gault VA; Hölscher C
    Eur J Pharmacol; 2008 Jun; 587(1-3):112-7. PubMed ID: 18466898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gly(14)]-humanin rescues long-term potentiation from amyloid beta protein-induced impairment in the rat hippocampal CA1 region in vivo.
    Guo F; Jing W; Ma CG; Wu MN; Zhang JF; Li XY; Qi JS
    Synapse; 2010 Jan; 64(1):83-91. PubMed ID: 19768812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo.
    Freir DB; Herron CE
    J Neurophysiol; 2003 Jun; 89(6):2917-22. PubMed ID: 12611941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo.
    Cheng L; Yin WJ; Zhang JF; Qi JS
    Synapse; 2009 Mar; 63(3):206-14. PubMed ID: 19072840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo.
    Schmid AW; Lynch MA; Herron CE
    Hippocampus; 2009 Jul; 19(7):670-6. PubMed ID: 19115392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of LTP in vivo by beta-amyloid peptide in different conformational states.
    Schmid AW; Freir DB; Herron CE
    Brain Res; 2008 Mar; 1197():135-42. PubMed ID: 18237717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.
    Hu NW; Smith IM; Walsh DM; Rowan MJ
    Brain; 2008 Sep; 131(Pt 9):2414-24. PubMed ID: 18678563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Administration of aggregated beta-amyloid peptide (25-35) causes change in long-term potentiation in the hippocampus].
    Trubetskaia VV; Stepanichev MIu; Onufriev MV; Lazareva NA; Markevich VA; Guliaeva NV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2001; 51(6):690-3. PubMed ID: 11871032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons.
    Nomura I; Kato N; Kita T; Takechi H
    Neurosci Lett; 2005 Dec; 391(1-2):1-6. PubMed ID: 16154266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation.
    Zhao D; Watson JB; Xie CW
    J Neurophysiol; 2004 Nov; 92(5):2853-8. PubMed ID: 15212428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCP-LA neutralizes mutant amyloid beta peptide-induced impairment of long-term potentiation and spatial learning.
    Nagata T; Tomiyama T; Mori H; Yaguchi T; Nishizaki T
    Behav Brain Res; 2010 Jan; 206(1):151-4. PubMed ID: 19716848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
    Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.